3D-printed flexible polymer stents for potential applications in inoperable esophageal malignancies.
Sign Up to like & getrecommendations! Published in 2019 at "Acta biomaterialia"
DOI: 10.1016/j.actbio.2018.10.035
Abstract: Palliation therapy for dysphagia using esophageal stents is the current treatment of choice for those patients with inoperable esophageal malignancies. However, the metallic and plastic stents currently used in the clinical setting may cause complications,… read more here.
Keywords: inoperable esophageal; polymer stents; stent spirals; polymer stent ... See more keywords
Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Gastrointestinal endoscopy"
DOI: 10.1016/j.gie.2018.04.2362
Abstract: BACKGROUND AND AIMS Dysphagia is a debilitating symptom in patients with inoperable esophageal cancer that contributes to poor quality of life and worsening nutritional status. The 2 most commonly used palliative modalities for dysphagia are… read more here.
Keywords: inoperable esophageal; esophageal cancer; cryotherapy; liquid nitrogen ... See more keywords
A Prospective Multicenter Study to Evaluate the Impact of Cryotherapy on Dysphagia and Quality of Life in Patients with Inoperable Esophageal Cancer.
Sign Up to like & getrecommendations! Published in 2023 at "Endoscopy"
DOI: 10.1055/a-2105-2177
Abstract: BACKGROUND AND STUDY AIMS Dysphagia palliation in inoperable esophageal cancer continues to be a challenge. Self-expanding metal stents have been the mainstay for endoscopic palliation but have a significant risk of adverse events (AE). Liquid… read more here.
Keywords: esophageal cancer; inoperable esophageal; dysphagia; cryotherapy ... See more keywords
Nimotuzumab in the Treatment of Inoperable Esophageal Tumors of Epithelial Origin
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Oncology"
DOI: 10.1155/2022/4128946
Abstract: Background Nimotuzumab is a humanized monoclonal antibody that targets the epidermal growth factor receptor. It was approved in Cuba for the indication of inoperable malignant tumors of the esophagus of epithelial origin. The purpose of… read more here.
Keywords: inoperable esophageal; esophageal tumors; progression free; epithelial origin ... See more keywords